Results 141 to 150 of about 3,810 (184)

Pharmacological Management for Prevention and Treatment of Posthepatectomy Liver Failure.

open access: yesDig Surg
Gerritsen A   +6 more
europepmc   +1 more source

Terlipressin: Current and emerging indications in chronic liver disease [PDF]

open access: yesJournal of Gastroenterology and Hepatology (Australia), 2018
Terlipressin is an analogue of vasopressin that has potent vasoactive properties and has been available for use in most countries for nearly two decades.
Paul Gow
exaly   +2 more sources

Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis

open access: yesJournal of Gastroenterology and Hepatology (Australia), 2005
BACKGROUND AND AIM: Terlipressin and somatostatin are the most preferable agents for the control of variceal bleeding in cirrhotic patients. The present study evaluated the hemodynamic effects of somatostatin, terlipressin and somatostatin plus ...
Paraskevi, K.   +6 more
exaly   +1 more source

Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome

open access: yesAdvances in Therapy, 2008
Terlipressin is an analog of the natural hormone arginine-vasopressin. It is used in the treatment of patients with cirrhosis and bleeding esophageal varices (BEV) and in patients with hepatorenal syndrome (HRS): two of the most dramatic and feared ...
Søren Møller   +2 more
exaly   +2 more sources

Terlipressin Acetate

American Journal of Health-System Pharmacy, 2022
openaire   +2 more sources

Home - About - Disclaimer - Privacy